Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-DP23-002, Improving Health Outcomes for Patients With Inflammatory Bowel Disease; Amended Notice of Closed Meeting, 7729 [2023-02476]
Download as PDF
<![CDATA[
7729
Federal Register / Vol. 88, No. 24 / Monday, February 6, 2023 / Notices
0215, Exp. 3/31/2023)—Revision—
National Center for Health Statistics
(NCHS), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C.), as
amended, authorizes that the Secretary
of Health and Human Services (DHHS),
acting through NCHS, shall collect
statistics on the extent and nature of
illness and disability of the population
of the United States.
The National Death Index (NDI) is a
database containing identifying death
record information submitted annually
to NCHS by all the jurisdiction (states
and territories) vital statistics offices,
beginning with deaths in 1979. Searches
against the NDI file provide the
jurisdictions and dates of death, and the
death certificate numbers of deceased
study subjects. Using the NDI Plus
service, researchers have the option of
also receiving cause of death
information for deceased subjects, thus
reducing the need to request copies of
death certificates from the jurisdictions.
The NDI Plus option currently provides
the International Classification of
Disease (ICD) codes for the underlying
and multiple causes of death for the
years 1979–2021. Health researchers
must complete administrative forms in
order to apply for NDI services and
submit records of study subjects for
computer matching against the NDI file.
A three-year revision request is
submitted to continue the use of the two
administrative forms (the application
form and transmittal form) utilized in
the operation of the National Death
Index (NDI) program, along with
worksheets used to calculate related
fees. These forms are submitted by NDI
users when applying for use of the NDI
and when actually using the service. In
addition, this request includes the
electronic versions that replace the three
paper documents, one of which will
include a minor reduction in the
number of data collection items.
The total estimated annual burden
hours are 1,276. This represents an
increase of 489 hours from 787, due
primarily to the increase in
applications, and transmittal forms.
There is no cost to respondents except
for their time.
ESTIMATES OF ANNUALIZED BURDEN HOURS
Type of respondent
Researcher
Researcher
Researcher
Researcher
Researcher
.............................
.............................
.............................
.............................
.............................
Application Form—Electronic .................................................
Transmittal Form—Paper/Electronic ......................................
Early Transmittal Form—Paper/Electronic .............................
Fee Worksheet .......................................................................
Early Release Fee Worksheet ...............................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–02421 Filed 2–3–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
DDrumheller on DSK120RN23PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—DP23–002,
Improving Health Outcomes for
Patients With Inflammatory Bowel
Disease; Amended Notice of Closed
Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—DP23–
002, Improving Health Outcomes for
Patients with Inflammatory Bowel
Disease; March 8, 2023, 11:00 a.m.–3:00
p.m., EST, Teleconference, in the
original FRN. The meeting was
published in the Federal Register on
December 9, 2022, Volume 87, Number
236, page 75632.
VerDate Sep<11>2014
18:51 Feb 03, 2023
Number of
respondents
Form name
Jkt 259001
Number of
responses per
respondent
282
400
100
450
100
Average
burden per
response
(in hours)
1
3
3
1
1
150/60
18/60
18/60
15/60
5/60
The meeting is being amended to
change the meeting time and should
read as follows:
Date: March 8, 2023.
Time: 10:00 a.m.–3:00 p.m., EST.
The meeting is closed to the public.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
FOR FURTHER INFORMATION CONTACT:
Agency Forms Undergoing Paperwork
Reduction Act Review
Catherine Barrett, Ph.D., Scientific
Review Officer, National Center for
Chronic Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway,
Mailstop S107–3, Atlanta, Georgia
30341–3717; Telephone: (404) 718–
7664; Email: CBarrett@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–02476 Filed 2–3–23; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention
[30 Day–23–22HK]
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Surveillance of
HIV-related service barriers among
Individuals with Early or Late HIV
Diagnoses (SHIELD)’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on July 22,
2022, to obtain comments from the
public and affected agencies. CDC
received no comments to the previous
notice. This notice serves to allow an
additional 30 days for public and
affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
E:\FR\FM\06FEN1.SGM
06FEN1
]]>Agencies
[Federal Register Volume 88, Number 24 (Monday, February 6, 2023)]
[Notices]
[Page 7729]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02476]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)--DP23-002, Improving Health Outcomes for Patients
With Inflammatory Bowel Disease; Amended Notice of Closed Meeting
Notice is hereby given of a change in the meeting of the Disease,
Disability, and Injury Prevention and Control Special Emphasis Panel
(SEP)--DP23-002, Improving Health Outcomes for Patients with
Inflammatory Bowel Disease; March 8, 2023, 11:00 a.m.-3:00 p.m., EST,
Teleconference, in the original FRN. The meeting was published in the
Federal Register on December 9, 2022, Volume 87, Number 236, page
75632.
The meeting is being amended to change the meeting time and should
read as follows:
Date: March 8, 2023.
Time: 10:00 a.m.-3:00 p.m., EST.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT: Catherine Barrett, Ph.D., Scientific
Review Officer, National Center for Chronic Disease Prevention and
Health Promotion, CDC, 4770 Buford Highway, Mailstop S107-3, Atlanta,
Georgia 30341-3717; Telephone: (404) 718-7664; Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-02476 Filed 2-3-23; 8:45 am]
BILLING CODE 4163-18-P
